[go: up one dir, main page]

DK1768748T4 - Sammensætninger omfattende strontium og vitamin D og anvendelser deraf - Google Patents

Sammensætninger omfattende strontium og vitamin D og anvendelser deraf Download PDF

Info

Publication number
DK1768748T4
DK1768748T4 DK05750580.2T DK05750580T DK1768748T4 DK 1768748 T4 DK1768748 T4 DK 1768748T4 DK 05750580 T DK05750580 T DK 05750580T DK 1768748 T4 DK1768748 T4 DK 1768748T4
Authority
DK
Denmark
Prior art keywords
strontium
vitamin
compositions
pharmaceutical composition
relates
Prior art date
Application number
DK05750580.2T
Other languages
Danish (da)
English (en)
Other versions
DK1768748T3 (da
Inventor
John Nikolaj Hvarre Christensen
Original Assignee
Mokwalo Spf S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34972075&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1768748(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mokwalo Spf S A filed Critical Mokwalo Spf S A
Publication of DK1768748T3 publication Critical patent/DK1768748T3/da
Application granted granted Critical
Publication of DK1768748T4 publication Critical patent/DK1768748T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK05750580.2T 2004-06-25 2005-06-24 Sammensætninger omfattende strontium og vitamin D og anvendelser deraf DK1768748T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200400991 2004-06-25
DKPA200401733 2004-11-10
PCT/DK2005/000425 WO2006000224A2 (fr) 2004-06-25 2005-06-24 Compositions comprenant du strontium et de la vitamine d et utilisation de ces compositions

Publications (2)

Publication Number Publication Date
DK1768748T3 DK1768748T3 (da) 2010-02-01
DK1768748T4 true DK1768748T4 (da) 2019-06-11

Family

ID=34972075

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05750580.2T DK1768748T4 (da) 2004-06-25 2005-06-24 Sammensætninger omfattende strontium og vitamin D og anvendelser deraf

Country Status (15)

Country Link
US (1) US8658206B2 (fr)
EP (1) EP1768748B2 (fr)
JP (2) JP5070046B2 (fr)
KR (1) KR20070034075A (fr)
AT (1) ATE443541T1 (fr)
AU (1) AU2005256317B2 (fr)
BR (1) BRPI0512357A (fr)
CA (1) CA2571449C (fr)
DE (1) DE602005016803D1 (fr)
DK (1) DK1768748T4 (fr)
EA (1) EA011814B1 (fr)
IL (1) IL180144A0 (fr)
MX (1) MXPA06015187A (fr)
NO (1) NO20070206L (fr)
WO (1) WO2006000224A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2097137B1 (fr) * 2006-11-21 2012-09-19 Mokwalo SPF S.A. Compositions comprenant du strontium et leurs utilisations dans le traitement ou la prévention de la gingivite, la paradontite, la paradontite comme symptôme de maladies systémiques, et la nécrose de paradontopathies
US20080118603A1 (en) * 2006-11-21 2008-05-22 Lada Mark W Nutritional beverage for optimal bone health
AU2008242867B2 (en) * 2007-04-23 2014-01-23 Baxter Healthcare S.A. Fibrin compositions containing strontium compounds
EP2173321B1 (fr) * 2007-07-19 2024-12-18 DSM IP Assets B.V. Formulations d'ingrédients de santé lipophiles pouvant se présenter sous forme de comprimés
US8790714B2 (en) 2007-08-03 2014-07-29 Nucitec, S.A. De C.V. Compositions and methods for treatment and prevention of osteoarthritis
EP2416756A2 (fr) * 2009-04-10 2012-02-15 Mahmut Bilgic Compositions pharmaceutiques stables à forte biodisponibilité
FR2945748A1 (fr) * 2009-05-20 2010-11-26 Debregeas Et Associes Pharma Medicament a base de calcium et de vitamine d.
FR2953139B1 (fr) * 2009-11-27 2012-04-13 Servier Lab Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine
WO2012006475A1 (fr) * 2010-07-07 2012-01-12 Ardelyx, Inc. Composés et procédés pour l'inhibition du transport de phosphate
WO2012006477A1 (fr) 2010-07-07 2012-01-12 Ardelyx, Inc. Composés et procédés pour l'inhibition du transport de phosphate
JP5827327B2 (ja) 2010-07-07 2015-12-02 アーデリクス，インコーポレーテッド リン酸輸送を阻害する化合物及び方法
JP5827326B2 (ja) 2010-07-07 2015-12-02 アーデリクス，インコーポレーテッド リン酸輸送を阻害する化合物及び方法
EP2590656B1 (fr) 2010-07-07 2017-11-15 Ardelyx, Inc. Composés et procédés permettant d'inhiber le transport du phosphate
WO2012103575A1 (fr) * 2011-02-02 2012-08-09 Ent Technologies Pty Ltd Compositions et procédés pour le traitement de voies nasales
EP2530068A1 (fr) 2011-05-31 2012-12-05 Lacer, S.A. Nouveaux sels de strontium, leur synthèse et leur utilisation dans le traitement de l'ostéoporose
WO2014044756A1 (fr) * 2012-09-20 2014-03-27 Mokwalo SA Strontium en tant que composé antimicrobien

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345265A (en) * 1963-10-09 1967-10-03 Kendall & Co Multiple layer tablet with calcium salt central core separated from soluble fluoride outer coating
US3699221A (en) * 1965-02-23 1972-10-17 Murray L Schole Dental preparations
US3988434A (en) * 1972-08-07 1976-10-26 Schole Murray L Dental preparation
FR2633619B1 (fr) 1988-06-29 1991-02-08 Adir Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant
FR2651497B1 (fr) 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2658816A1 (fr) * 1990-02-27 1991-08-30 Adir Nouveaux sels de metaux alcalinoterreux d'oxa-polyacides leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5380530A (en) * 1992-12-29 1995-01-10 Whitehill Oral Technologies Oral care composition coated gum
US5624906A (en) * 1994-12-08 1997-04-29 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
CN1164603C (zh) 2001-09-29 2004-09-01 南京化工大学 1，6－二磷酸果糖锶盐系列化合物及其制备方法和在医药中的应用
FR2844795B1 (fr) 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates
FR2844796A1 (fr) 2002-09-24 2004-03-26 Servier Lab Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844797B1 (fr) 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
EP1745791B1 (fr) 2003-05-07 2013-06-26 Osteologix A/S Sels de strontium hydrosolubles pour le traitement d'affections de cartilage et/ou d'os
PL1622629T3 (pl) 2003-05-07 2013-12-31 Osteologix As Kompozycja do kontrolowanego uwalniania zawierająca sól strontu
ES2394782T3 (es) * 2003-05-07 2013-02-05 Osteologix A/S Composición con estroncio y vitamina D para la profilaxis y/o tratamiento de afecciones de cartílagos y/o huesos

Also Published As

Publication number Publication date
US20080026037A1 (en) 2008-01-31
EP1768748A2 (fr) 2007-04-04
KR20070034075A (ko) 2007-03-27
EA200700130A1 (ru) 2007-06-29
JP2008503504A (ja) 2008-02-07
AU2005256317A1 (en) 2006-01-05
IL180144A0 (en) 2007-06-03
MXPA06015187A (es) 2007-09-27
DE602005016803D1 (de) 2009-11-05
CA2571449A1 (fr) 2006-01-05
EP1768748B2 (fr) 2019-03-13
WO2006000224A2 (fr) 2006-01-05
DK1768748T3 (da) 2010-02-01
ATE443541T1 (de) 2009-10-15
BRPI0512357A (pt) 2008-03-04
EP1768748B1 (fr) 2009-09-23
NO20070206L (no) 2007-03-22
HK1102427A1 (en) 2007-11-23
WO2006000224A3 (fr) 2006-05-18
AU2005256317B2 (en) 2011-09-15
EA011814B1 (ru) 2009-06-30
JP2012193208A (ja) 2012-10-11
US8658206B2 (en) 2014-02-25
JP5070046B2 (ja) 2012-11-07
CA2571449C (fr) 2015-12-08

Similar Documents

Publication Publication Date Title
NO20070206L (no) Sammensetninger inneholdende strontium og vitamin D og anvendelser derav
NO2023022I1 (no) cobimetinib, optionally in any form protected by the basic patent, including harmaceutically acceptable salts and sovates thereof, particularly cobimetinib hemifumarate
IN2012DN01233A (fr)
ZA200806778B (en) N-Hydroxyacrylamide compounds
MX2009014235A (es) 4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso.
EA201070699A1 (ru) Композиции 3-(6-(1-2,2-дифторбензо[d][1,3]диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
MY143795A (en) Tetrahydropyridoindole derivatives
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
TW200732296A (en) Novel compounds
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
MX2009013501A (es) Compuestos piperidinicos y sus usos.
TW200716204A (en) Pharmaceutical composition
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
EA200702282A1 (ru) Комбинация феррохина и производного артемизинина для лечения малярии
EA201170101A1 (ru) Фармацевтические композиции роувастатина кальция
GB0524814D0 (en) Compounds
TW200800993A (en) Organic compounds
TW200745081A (en) Compounds
DK1784173T3 (da) Farmaceutisk sammensætning til forebyggelse og behandling af metaboliske knoglesygdomme indeholdende alpha-arylmethoxyacrylatderivater
DK1893237T3 (da) Farmaceutisk sammensætning, der omfatter en organopolysiloxan ela-stomer og et solubiliseret aktivt stof
WO2007087026A3 (fr) Forme solide de amg 706 et compositions pharmaceutiques contenant ledit composé
MX2008001608A (es) Piperazinas acetilenicas como antagonistas de receptor de glutamato metabotropico.
GB0327390D0 (en) Pharmaceutical formulations
NO20063790L (no) Substituerte azetidin sammensetninger som cyclooxygenase-1-cyclooxygenase-2-inhibitorer, og deres fremstilling og anvendelse som medikamenter
ZA200706705B (en) Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof